학술논문
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Document Type
Article
Author
Karasik, Avraham; Lanzinger, Stefanie; Chia-Hui Tan, Elise; Yabe, Daisuke; Kim, Dae Jung; Sheu, Wayne H-H; Melzer-Cohen, Cheli; Holl, Reinhard W.; Ha, Kyoung Hwa; Khunti, Kamlesh; Zaccardi, Francesco; Subramanian, Anuradhaa; Nirantharakumar, Krishnarajah; Nyström, Thomas; Niskanen, Leo; Linnemann Jensen, Majken; Hoti, Fabian; Klement, Riho; Déruaz-Luyet, Anouk; Kyaw, Moe H.; Koeneman, Lisette; Vistisen, Dorte; Carstensen, Bendix; Halvorsen, Sigrun; Langslet, Gisle; Fazeli Farsani, Soulmaz; Patorno, Elisabetta; Núñez, Júlio
Source
In Diabetes & Metabolism March 2023 49(2)
Subject
Language
ISSN
1262-3636